Tomohiro Makino

489 total citations
25 papers, 364 citations indexed

About

Tomohiro Makino is a scholar working on Molecular Biology, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tomohiro Makino has authored 25 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Economics and Econometrics and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tomohiro Makino's work include Pharmaceutical Economics and Policy (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (3 papers). Tomohiro Makino is often cited by papers focused on Pharmaceutical Economics and Policy (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (3 papers). Tomohiro Makino collaborates with scholars based in Japan, United States and Greece. Tomohiro Makino's co-authors include George Georgiou, Γεώργιος Σκρέτας, Kota Kodama, Yeongjoo Lim, Shintaro Sengoku, Navin Varadarajan, Mark Pogson, Ryuichi Nakamura, Maki Terakawa and Kimiaki Utsugisawa and has published in prestigious journals such as PLoS ONE, Scientific Reports and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Tomohiro Makino

24 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Makino Japan 8 231 73 68 47 40 25 364
Jim Kling United States 12 245 1.1× 22 0.3× 78 1.1× 13 0.3× 31 0.8× 55 495
О.Г. Леонова Russia 11 208 0.9× 33 0.5× 30 0.4× 32 0.7× 25 0.6× 54 420
Arthur Klausner United States 10 202 0.9× 30 0.4× 42 0.6× 16 0.3× 40 1.0× 71 349
Christian Hoffmeister Germany 4 238 1.0× 54 0.7× 40 0.6× 46 1.0× 43 1.1× 7 274
Amanda Dugan United States 9 189 0.8× 29 0.4× 20 0.3× 18 0.4× 4 0.1× 15 306
Michelle Burger Australia 6 265 1.1× 25 0.3× 45 0.7× 22 0.5× 36 0.9× 15 414
Ina Theobald Germany 6 336 1.5× 197 2.7× 26 0.4× 22 0.5× 32 0.8× 7 459
Natalia I. Majewska United States 9 464 2.0× 155 2.1× 63 0.9× 36 0.8× 70 1.8× 12 525
M.E. Nilsson Sweden 14 389 1.7× 17 0.2× 176 2.6× 49 1.0× 17 0.4× 19 542

Countries citing papers authored by Tomohiro Makino

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Makino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Makino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Makino more than expected).

Fields of papers citing papers by Tomohiro Makino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Makino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Makino. The network helps show where Tomohiro Makino may publish in the future.

Co-authorship network of co-authors of Tomohiro Makino

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Makino. A scholar is included among the top collaborators of Tomohiro Makino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Makino. Tomohiro Makino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Sayaka, et al.. (2025). Selective agonists of KIR and NKG2A to evade missing self response of natural killer cells. Scientific Reports. 15(1). 33550–33550.
2.
Masuda, Kenji, Kazuhiko Watanabe, Naoto Ishikawa, et al.. (2024). Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing. Journal of Bioscience and Bioengineering. 137(6). 471–479. 2 indexed citations
3.
Makino, Tomohiro, et al.. (2020). International Strategy for Sustainable Growth in Multinational Pharmaceutical Companies. Sustainability. 12(3). 867–867. 17 indexed citations
4.
Makino, Tomohiro, et al.. (2020). Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies. Sustainability. 12(13). 5358–5358. 13 indexed citations
5.
Makino, Tomohiro, et al.. (2020). Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth. Sustainability. 12(21). 8938–8938. 5 indexed citations
6.
Miyazaki, Kazuo, Kouichi Uoto, Maki Terakawa, et al.. (2020). Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers. Bioorganic & Medicinal Chemistry Letters. 30(19). 127425–127425. 4 indexed citations
7.
Yamaguchi, Naoya, et al.. (2019). Holistic cost-effectiveness analysis of anticancer drug regimens in Japan. Drug Discovery Today. 25(2). 269–273. 5 indexed citations
8.
Makino, Tomohiro, et al.. (2019). Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model. Biochemical Pharmacology. 171. 113717–113717. 6 indexed citations
9.
Makino, Tomohiro, Yeongjoo Lim, & Kota Kodama. (2018). Strategic R&D transactions in personalized drug development. Drug Discovery Today. 23(7). 1334–1339. 10 indexed citations
10.
Nakamura, Ryuichi, Tomohiro Makino, Takeshi Hanada, et al.. (2018). Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology. 320. 64–75. 2 indexed citations
11.
Makino, Tomohiro, Shintaro Sengoku, Shuichi Ishida, & Kota Kodama. (2018). Trends in interorganizational transactions in personalized medicine development. Drug Discovery Today. 24(2). 364–370. 6 indexed citations
12.
Nakamura, Ryuichi, et al.. (2018). Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA system. Journal of Bioscience and Bioengineering. 126(4). 522–526. 4 indexed citations
13.
Makino, Tomohiro, Ryuichi Nakamura, Maki Terakawa, et al.. (2017). Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools. PLoS ONE. 12(10). e0185976–e0185976. 20 indexed citations
14.
Makino, Tomohiro, et al.. (2016). Activation Timing in a Vehicle-to-Vehicle Communication System for Traffic Collision. SAE technical papers on CD-ROM/SAE technical paper series. 1. 1 indexed citations
15.
Makino, Tomohiro, Masaru Matsumoto, & Yoshiharu Minamitake. (2012). Synthesis of Ghrelin. Methods in enzymology on CD-ROM/Methods in enzymology. 514. 183–203. 1 indexed citations
16.
Σκρέτας, Γεώργιος, Tomohiro Makino, Navin Varadarajan, Mark Pogson, & George Georgiou. (2012). Multi-copy genes that enhance the yield of mammalian G protein-coupled receptors in Escherichia coli. Metabolic Engineering. 14(5). 591–602. 24 indexed citations
17.
Makino, Tomohiro, Γεώργιος Σκρέτας, & George Georgiou. (2011). Strain engineering for improved expression of recombinant proteins in bacteria. Microbial Cell Factories. 10(1). 32–32. 150 indexed citations
18.
Makino, Tomohiro, et al.. (2010). Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. Metabolic Engineering. 13(2). 241–251. 57 indexed citations
19.
Makino, Tomohiro, Masaru Matsumoto, Yuji Suzuki, et al.. (2005). Semisynthesis of human ghrelin: Condensation of a Boc‐protected recombinant peptide with a synthetic O‐acylated fragment. Biopolymers. 79(5). 238–247. 17 indexed citations
20.
Saito, T, Sanshiro Hanada, Yasuo Kuwazuru, et al.. (1989). [Expressions of 2H4 and 4B4 antigens on ATL cells].. PubMed. 30(4). 443–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jim Kling Breakdown of academic impact, for papers by О.Г. Леонова Breakdown of academic impact, for papers by Arthur Klausner Breakdown of academic impact, for papers by Christian Hoffmeister Breakdown of academic impact, for papers by Amanda Dugan Breakdown of academic impact, for papers by Michelle Burger Breakdown of academic impact, for papers by Ina Theobald Breakdown of academic impact, for papers by Natalia I. Majewska Breakdown of academic impact, for papers by M.E. Nilsson
Rankless by CCL
2026